Capital Flow Monitor · Sponsors · CIK 2082715
Plexium, Inc.
9330 SCRANTON ROAD, SUITE 500, SAN DIEGO, CA, 92121 · (858) 263-7491
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$60.1M
Sold
$60.1M
% sold
100.0%
Investors
20
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-25 | D ·current | 506(b) | $60.1M | $60.1M | 100.0% | 20 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Michael Martin — Executive Officer / Director, San Diego, CA
3 other raises
- QCP Income & Growth Fund, L.P. $100.0M of —
- QuadCP Fund II, LP $210.0M of —
- r.World, PBC $7.9M of $10.0M · 78.8%
-
Michael Grey — Director, San Diego, CA
2 other raises
- Mirum Pharmaceuticals, Inc. $68.5M of $68.5M · 100.0%
- SPRUCE BIOSCIENCES, INC. $50.0M of $50.0M · 100.0%
-
Patrick Rivers — Director, San Diego, CA
1 other raise
- aMoon Edge Limited Partnership $42.6M of —
- Leon Chen — Director, San Diego, CA
- Gorjan Hrustanovic — Director, San Diego, CA
-
Serge Messerlian — Director, San Diego, CA
1 other raise
- Auron Therapeutics, Inc. $27.3M of $42.3M · 64.5%
- Rob Hopfner — Director, San Diego, CA
-
Cariad Chester — Director, San Diego, CA
1 other raise
- Ollin Biosciences, Inc. $156.2M of $330.0M · 47.3%
- Stephen Mullennix — Executive Officer, San Diego, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.